Abstract

BackgroundRecently, high proportions (15.6%–98.7%) of intravenous drug users (IDUs) in China were found to be positive for hepatitis C virus (HCV). Yunnan Province is located in southwestern China and borders one of the world's most important opium-producing regions, thus it is an important drug trafficking route to other regions of China.Methodology/Principal FindingsHere, we assessed 100 HCV-positive plasma samples from IDUs who were enrolled through the Kunming Center for Disease Control and Prevention in 2012. HCV C/E1 fragments were PCR-amplified and sequenced. We identified eight HCV subtypes (1a, 1b, 3a, 3b, 6a, 6n, 6u and 6v), of which genotype 6 was most predominant (frequency, 47%) followed by genotypes 3 (41%) and 1 (12%). HCV subtypes 6n (30%) and 3b (29%) were most common and were identified in 59% of the IDUs. We compared HCV genotypes among IDUs in Yunnan Province with those from other regions and found that the distribution patterns of HCV genotypes in Yunnan Province were similar to those in southern China, but different from those in eastern China. However, the distribution patterns of HCV subtypes varied among Yunnan Province and southern China, despite the shared similar genotypes. A comparison of the current data with those previously reported showed that the frequency of HCV genotype 6 increased from 25% to 47% within 5 years, especially subtypes 6a (5% to 15%) and 6n (11.2% to 30%). In contrast, the frequencies of subtypes 3b and 1b decreased by almost 50% within 5 years.Conclusion/SignificanceOur results provided further information to support the assertion that drug trafficking routes influence HCV transmission patterns among IDUs in Yunnan Province. The frequency of HCV genotypes and subtypes changed rapidly among IDUs in Yunnan Province and subtypes 6a and 6n may have originated in Vietnam and Myanmar, respectively.

Highlights

  • Hepatitis C virus (HCV) is considered a principal cause of chronic liver disease, such as liver fibrosis, liver cirrhosis, and hepatocellular carcinoma, and currently infects about 170 million people worldwide [1,2]

  • Conclusion/Significance: Our results provided further information to support the assertion that drug trafficking routes influence hepatitis C virus (HCV) transmission patterns among intravenous drug users (IDUs) in Yunnan Province

  • Prevalent HCV subtypes among IDUs in Yunnan Province HCV C/E1 fragments were amplified successfully from all HCV-positive samples

Read more

Summary

Introduction

Hepatitis C virus (HCV) is considered a principal cause of chronic liver disease, such as liver fibrosis, liver cirrhosis, and hepatocellular carcinoma, and currently infects about 170 million people worldwide [1,2]. Individuals at high-risk for HCV infection include and percutaneous and intravenous drug users (IDUs), those receiving transfusion of blood products and hemodialysis, as well as those who engage in unprotected sex with multiple sex partners [4]. In 2012, Zhou et al reported the prevalence of HIV, HCV, HBV and co-infection among IDUs. In 2012, Zhou et al reported the prevalence of HIV, HCV, HBV and co-infection among IDUs They found the association of these viruses with high risk intravenous drug use behaviors in Yunnan Province and observed that a high proportion (77.7%) of IDUs were HCV-positive. High proportions (15.6%–98.7%) of intravenous drug users (IDUs) in China were found to be positive for hepatitis C virus (HCV). Yunnan Province is located in southwestern China and borders one of the world’s most important opium-producing regions, it is an important drug trafficking route to other regions of China

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call